Kevin Bitterman, Director at Disc Medicine, Inc. (IRON), sold 144,040 shares at $77.16 ($12.3M) on 2025-10-15, disclosed to the SEC on 2025-10-17.
Open-market sale of $12.3M IRON by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.16 | 19,542 | $1.5M | 12.3% |
| 2 | $77.16 | 19,542 | $1.5M | 12.3% |
| 3 | $77.76 | 2,618 | $204K | 1.7% |
| 4 | $77.76 | 2,618 | $204K | 1.7% |
| 5 | $77.11 | 1,425 | $110K | 0.9% |
| 6 | $77.11 | 1,425 |
| $110K |
| 0.9% |
| 7 | $84.89 | 1,125 | $96K | 0.8% |
| 8 | $84.89 | 1,125 | $96K | 0.8% |
| 9 | $86.13 | 3,000 | $258K | 2.1% |
| 10 | $87.37 | 5,065 | $443K | 3.6% |
| 11 | $87.37 | 5,066 | $443K | 3.6% |
| 12 | $87.37 | 5,066 | $443K | 3.6% |
| 13 | $87.37 | 5,065 | $443K | 3.6% |
| 14 | $88.91 | 13,014 | $1.2M | 9.4% |
| 15 | $88.91 | 13,014 | $1.2M | 9.4% |
| 16 | $89.70 | 2,251 | $202K | 1.6% |
| 17 | $89.70 | 2,251 | $202K | 1.6% |
| 18 | $90.66 | 10,094 | $915K | 7.5% |
| 19 | $90.66 | 10,095 | $915K | 7.5% |
| 20 | $90.66 | 10,095 | $915K | 7.5% |
| 21 | $90.66 | 10,094 | $915K | 7.5% |
| 22 | $91.88 | 450 | $41K | 0.3% |
| Total | $85.27 avg | 144,040 | $12.3M | 100% |
| Filing → |
| IRON | SELL | 2026-09-03 | $4.4M | — | Filing → |
| IRON | SELL | 2025-12-18 | $69K | — | Filing → |
| IRON | SELL | 2025-12-16 | $33.1M | — | Filing → |